Pre-Market
S&P 500 $771.77 +0.28% DOW $521.14 +1.07% NASDAQ $728.00 -0.13% BTC $82,527 +1.98%
ABBV
AbbVie Inc
NYSE HEALTHCARE
$283.40
+$1.64 (+0.58%)
Delayed 15 min · Oct 16, 12:14 PM UTC
Open
$288.28
High
$291.40
Low
$282.81
Prev Close
$281.76
Volume
7.62M

Price Chart

About AbbVie Inc

AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.

📊 HEALTHCARE 🏭 DRUG MANUFACTURERS - GENERAL 🌍 USA

ABBV News

Iambic Therapeutics, AI-Driven Drug Discovery and Development, Files for Nasdaq Global Select Market IPO
TradingView • 8h ago Bullish
Friedreich’s Ataxia Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | AbbVie, Minoryx Therapeutics, Takeda, Reata Pharma, Design Therapeutics
StreetInsider • 14h ago
Healthcare Stocks Are on a Tear. Gilead and AbbVie Are Heading for Record Highs.
Barron's • 16h ago Bullish
Mizuho sets USD 22.00 target for REGENXBIO stock
ad-hoc-news.de • 18h ago Somewhat-Bullish
Bristol, AbbVie Seek Intervention in Suit Over Drug Rebate Pilot
Bloomberg Law News • 18h ago
Bristol, AbbVie Seek Intervention in Suit Over Drug Rebate Pilot
Bloomberg Government News • 18h ago
Bristol, AbbVie Seek Intervention in Suit Over Drug Rebate Pilot
Bloomberg Law News • 18h ago
Bristol, AbbVie Seek Intervention in Suit Over Drug Rebate Pilot
Bloomberg Law News • 18h ago Somewhat-Bearish

Key Statistics

Market Cap
484.83B
P/E Ratio
77.5
EPS
$3.54
Beta
0.228
52W High
$283.66
52W Low
$188.25
Div Yield
2.43%
Avg Volume
7.62M

Related Stocks

AAPL
Apple
MSFT
Microsoft
GOOGL
Alphabet
AMZN
Amazon
TSLA
Tesla

💬 Discussion

Loading...
Loading comments...